Chemed (CHE)
(Delayed Data from NYSE)
$567.96 USD
-1.04 (-0.18%)
Updated May 15, 2024 04:00 PM ET
After-Market: $566.60 -1.36 (-0.24%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Top 19% (56 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.68 | 9.99 |
Current Quarter Estimate | 5.62 | 0.69 | 57.00 |
Year Ago Quarter Estimate | 4.71 | 1.31 | 52.54 |
Next Quarter Estimate | 5.85 | 0.72 | 61.00 |
Next Year Estimate | 25.58 | 5.93 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 15.17 | 11.80 | 15.67 |
Next Year | 9.41 | 15.40 | 9.31 |
Last 5 Years | 14.10 | 6.50 | 8.10 |
Next 5 Years | 11.30 | 12.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 26.07 | 13.83 |
Price/Book (MRQ) | 7.28 | 2.47 |
Price/Cash Flow (MRFY) | 23.17 | 13.29 |
Dividend Yield | 0.28% | 0.00% |
Net Profit Margin (TTM) | 12.36% | 2.86% |
Return on Equity (TTM) | 30.52% | 10.22% |
Debt to Equity (MRQ) | 0.00 | 35.57 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.